Cyclacel Pharmaceuticals to Release Second Quarter 2022 Financial Results
Provided By Globe Newswire
Last update: Aug 3, 2022
BERKELEY HEIGHTS, N.J., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, will announce second quarter 2022 financial results on Wednesday, August 10, 2022. The company will host a conference call and live webcast at 4:30 p.m. Eastern Daylight Time on the same day.
NASDAQ:CYCC (7/14/2025, 2:05:16 PM)
3.39
-0.32 (-8.63%)
CYCLACEL PHARMACEUTICALS - CYCC 6 PERP
NASDAQ:CYCCP (7/11/2025, 8:02:39 PM)
Premarket: 5.25 +0.34 (+6.92%)4.91
-0.05 (-1.01%)
Find more stocks in the Stock Screener
CYCC Latest News and Analysis
12 days ago - ChartmillTop movers in Wednesday's sessionStay up-to-date with the latest market trends one hour before the close of the markets on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
12 days ago - ChartmillThese stocks are moving in today's sessionCurious about what's happening in today's session? Check out the latest stock movements and price changes.
12 days ago - ChartmillGapping stocks in Wednesday's sessionLet's delve into the US markets on Wednesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
